Geode Capital Management
THRD

Geode Capital Management’s Third Harmonic Bio THRD Stock Holding History

Geode Capital Management’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-577,190
Closed -$3.13M – 4563
2025
Q2 		$3.13M Buy
577,190
+62,303
+12% +$311K ﹤0.01% 2966
2025
Q1 		$1.79M Buy
514,887
+33,028
+7% +$160K ﹤0.01% 3083
2024
Q4 		$4.96M Buy
481,859
+41,537
+9% +$518K ﹤0.01% 2752
2024
Q3 		$5.97M Buy
440,322
+7,845
+2% +$97.2K ﹤0.01% 2671
2024
Q2 		$5.62M Buy
432,477
+32,409
+8% +$401K ﹤0.01% 2661
2024
Q1 		$3.78M Sell
400,068
-625
-0.2% -$6.08K ﹤0.01% 2852
2023
Q4 		$4.4M Buy
400,693
+39,538
+11% +$313K ﹤0.01% 2770
2023
Q3 		$2.31M Buy
361,155
+44,480
+14% +$272K ﹤0.01% 3026
2023
Q2 		$1.52M Buy
316,675
+72,483
+30% +$345K ﹤0.01% 3198
2023
Q1 		$1.01M Buy
244,192
+13,582
+6% +$57.7K ﹤0.01% 3344
2022
Q4 		$991K Buy
+230,610
New +$3.86M ﹤0.01% 3340

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management's THRD Position: Q3 2025 in Review

Geode Capital Management sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 577,190 shares — an estimated $3.13M sold.

Geode Capital Management first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $5.97M in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Geode Capital Management reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Geode Capital Management sold 577,190 Third Harmonic Bio shares in Q3 2025, an estimated $3.13M.
  • Geode Capital Management first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • Geode Capital Management's Third Harmonic Bio position peaked at $5.97M in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.